{"name":"Kivu Bioscience Inc.","slug":"kivu-bioscience-inc","ticker":"","exchange":"","domain":"kivu.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNMzQyR0VmSU01clVsSG1tRzd4eTF0TmZvS09WNFA3VHI2bWZmVDY3emY1Nmhrd2VuYlZ6NG9jTDVyVERnZGFOSE93Zmw1QmJuSVFla1hpZXNCUC1JRkxlcjNxTkM1TWNNOWhsT2pqdk80RURTa1JBRS1tVGNoaDV0cUgtRUk5SVdNYmIzbVN6Rl9wRHlqMlI0YTlOS0pEV1lsbmF2R1dnSnMwcmd1c0xR?oc=5","date":"2026-03-03","type":"pipeline","source":"Contract Pharma","summary":"Kivu Bioscience Appoints Brunilda Shtylla Chief Business Officer - Contract Pharma","headline":"Kivu Bioscience Appoints Brunilda Shtylla Chief Business Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxObmhBTUgzQVpjMnZfTGJvYUJENlFmTEQtbEdBZnBzeVUyM29GUVpjeWVXMkpLMFJBQU9jWmZrTHZtdmZ2bGFUeHVUd21YYzU4emthZ3JKRndHZ2NUalFWMkJFZlVobTFBeFBMN0lHUVNrZnF4SEtDTWtUZ2FWU2lwZGNiczNyTWw3SVhka3pXaU1EeXFCT2xpZUZWNERIXzJvTmktZDI4SGxVYVUzNW5rUWZneC1kaVUtR1gyYlRadFVmTzVET2E4amFKaTNvRUw2UExrZy1sU1VVWUNfa1lqcTNadHhkSHNwcDJXZ1JNZUNtanBmRnA1ZlFuYmJFQTdOb3VB?oc=5","date":"2026-02-25","type":"trial","source":"businesswire.com","summary":"Kivu Bioscience Presents KIVU-305 Preclinical Data at World ADC London 2026 and Advances into Phase 1 Clinical Trial - businesswire.com","headline":"Kivu Bioscience Presents KIVU-305 Preclinical Data at World ADC London 2026 and Advances into Phase 1 Clinical Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQWXJqYWtKZWduQkEwUXhDdThBZXd5OFdabURLUmxDNzVQb0QwS2RwSEFHV2xQOWUzT1RiQWhZZFNPMC1vOUdLbnotTHVQcEp5MUdJSkp6bE9uRWtIcVBqOHM0UkVibnNwUC1NVmd0cjI1UnFfUGNGajUwWWthakJjcjFNa19sTVJpNFdhRzhhOWpFTHhxOVhfenl0aDlmRC1uLXNzWWRtOHZWWTZEUllSUHUxN2l0VGhFck5wWHVObmJjYWZZcC1V?oc=5","date":"2026-01-27","type":"pipeline","source":"businesswire.com","summary":"Kivu Bioscience Appoints Julie Hambleton, M.D., to its Board of Directors - businesswire.com","headline":"Kivu Bioscience Appoints Julie Hambleton, M.D., to its Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAJBVV95cUxPWkl0eWoxOG5vZE5JekRNYjBlVW5GU3pxZk1uTWFEMnNBS2JpYkJSMDJFc1VBOVRsdHVaZC04elRhbXp3QnJGQ20wNUlRZW5XRmxXN0JHRVBtMzdpSW9VZVNqM2pDYjZITGVQbGZQclhaWDc2SDVsQUxGR05GNGxRX0VycHE5MmxBaFJHS09FdWdlX2FfeHgtbE5BZHp3MWV6R004Wk1vQnU0T0txbWMxWl9jU1ZDWEIwTGpkM2QxVEdkMGdUZXdjQUMyWWZzcnZyajZVaVRrVVA0VmRnQnVOZWE5VEM0VWZGanFJb3h2Yk1XNlZwSks2aHRUVlE5YXBrWkl1Yko5aTlHUktQVHJHSXBzMGVkUHRIZUlnbQ?oc=5","date":"2026-01-12","type":"trial","source":"businesswire.com","summary":"Kivu Bioscience Announces First Patient Dosed in Phase 1 Trial of KIVU-107 Next-Generation PTK7-Targeting ADC for Advanced Solid Tumors - businesswire.com","headline":"Kivu Bioscience Announces First Patient Dosed in Phase 1 Trial of KIVU-107 Next-Generation PTK7-Targeting ADC for Advanc","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxPakVXLTl5ZS14LWNsd0lLNlNhOFFHbkNrYXhpTWNkc05GQ21pZFdmLWpYMU5nenc4cGZ5dWNqVTNocHhCSVlYVlo2WHhtTEVlWmVWR3N4bWE3QzNfMkRLYTltLTdLUmFuUUNfeXFXSjR2OUlfLXFlV3pPSXhzaGVjemFkV1ZIbnhCc3Q3WkdWZ0RWX2V1djctVzBtNTBILXp5dldwOG9qb19VeEk4bnN1SGxfZC1BR2x3UENtM2dhMFVGSGtzdktKbG96UUxFUQ?oc=5","date":"2025-10-27","type":"pipeline","source":"businesswire.com","summary":"Kivu Bioscience Appoints Sophia Randolph, M.D., Ph.D., as Chief Medical Officer - businesswire.com","headline":"Kivu Bioscience Appoints Sophia Randolph, M.D., Ph.D., as Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwJBVV95cUxPZVo0Mzc1am5XOFFrNE04MmNzNFgwSTNFU2x6RjU5RkFZUUVyZGJmNS00TXR2bzFLZzVNTkhhT1lrY3pJcFo4dXJKZ3hJRmpnVkt5eFVtYV9uekNhV01uMkVwc2VSSDRXX3ItOGE1QUJIT0xJUG5yUTdlSzhwSmtLbEx4bThqYmxjNkt3MVVSTWN4S2J6N21DS3RGVTJobGNjaXEtMXRsMEg2MnE3VjVEZmdIT214cHVqTjduNFJyaVQtUzRqNk5HR0VKYlJHRmlMTXJwNUtFcXFtYmNxeEFlNHlYTG5VQTl2QmtWQkZwNmdWeVNJZ2I3X0JQLUk0MlR1bXhhZzJ6UVRzWmdxdTdWd1ZLWFU0ZE1EMTVmdXpadXlIMm9ZbXNITEdHeWJwNVMzZGVnUU5Mc0ZmNWhOZjhCMXB2cw?oc=5","date":"2025-10-20","type":"trial","source":"businesswire.com","summary":"Kivu Bioscience Presents Preclinical Data for KIVU-107 Demonstrating Potent and Durable Anti-Tumor Activity and a Wide Therapeutic Index at World ADC San Diego 2025 - businesswire.com","headline":"Kivu Bioscience Presents Preclinical Data for KIVU-107 Demonstrating Potent and Durable Anti-Tumor Activity and a Wide T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE1za2VJcUxTMDEweTR1elB1NzVTYnNiYmppY3FUbjk4SWhoclRzSnFGMVV4TzZEci1NOHcxUE9Idk10NExtcUl5VkRfa3NWNDRNWEFoWG41TGhPYTZPY1dENjFJcXg5XzllZm5nenFjbkU5ZHZOUkNub3ZDNXU4Zw?oc=5","date":"2024-10-28","type":"pipeline","source":"The Pharma Letter","summary":"Kivu Bioscience raises $92 million - The Pharma Letter","headline":"Kivu Bioscience raises $92 million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxNZ29PLWx0cjFndTM5c2VJVmVodHV1MkNnMVd2RFk4SldWVWFzaG84Vms5Y1dWczBzTFB2d3k0WTF4U1c5Z1ZnZ1FHclE3SlBLa1g4c25oUTV3NG93OVoteGZqUUhaaVFTVlJFVEZjY2g5WVcwUW40UVFTYjVSRFpkQnFtZUNVRTlBeGJXaTJkendfdFZiRTlIRkplVWk0eDVjR0RXQjZYcVhyR2NqVW1pQ01jODdmbC1lbVVMQlo5eTA1U1lwU1pBSndCT3hCXzVPVjg0Q2lFQVc4elJUMEFZUm9KM0gzLWZ3S2dmQ1FVVGw2aExWeEJNd3VYZEVNSUFjcE5Bbk5B?oc=5","date":"2024-10-28","type":"pipeline","source":"businesswire.com","summary":"Kivu Bioscience Raises $92 Million Series A Led by Novo Holdings to Advance Next-Generation Antibody-Drug Conjugates - businesswire.com","headline":"Kivu Bioscience Raises $92 Million Series A Led by Novo Holdings to Advance Next-Generation Antibody-Drug Conjugates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNQlRZdVJicmR1LVdNRlU0SWdtM2Fmakw5ZDBqVUJFT1ZNLVB5X0lLY1R6ZDVfbHlBNDJMWmZWTmpIUzUwODFON2t0YlU4aDZ3VHZEbXpZMkNVMWFjblV2SHFpSmg2c05QUkZieEFBVVZCMHhfZGJtLUdnNXhBejZBSVBXTTh4cEZQQ2Q4b1BtZmtGdVowVEtqSg?oc=5","date":"2024-10-27","type":"pipeline","source":"BioPharma Dive","summary":"With $92M, Kivu sets out to make ‘kinder, gentler’ ADCs - BioPharma Dive","headline":"With $92M, Kivu sets out to make ‘kinder, gentler’ ADCs","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}